Fortress Biotech Inc. (NASDAQ: FBIO) Starts Presentation at The LD 500
Fortress Biotech Inc. (NASDAQ: FBIO) is an innovative biopharmaceutical company that was recently ranked number 10 in Deloitte's 2019 Technology Fast 500(TM). Fortress is focused on acquiring, developing and commercializing high-potential marketed and development-stage drugs and drug candidates. The company has five marketed prescription pharmaceutical products and over 25 programs in development at Fortress, at its majority-owned and majority-controlled partners, and at partners it founded and in which it holds significant minority ownership positions. Such product candidates span six large-market areas, including oncology, rare diseases and gene therapy. Fortress has established partnerships with some of the world's leading academic research…